Results 111 to 120 of about 9,620 (164)

Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data. [PDF]

CPT Pharmacometrics Syst Pharmacol
Bracis C, Taneja A, Lyauk YK, Barcomb H, de la Peña A, Cellière G.   +5 more
europepmc   +1 more source

Targeting NLRP3 Inflammasomes in Myocarditis: Potential Therapeutic Strategies and Clinical Translation. [PDF]

Scientifica (Cairo)
Retnowati FD, Halawa DR, Maayah ZH, Abdallah AM.   +3 more
europepmc   +1 more source

Anti-Inflammatory Therapies in Acute Coronary Syndromes-A Review of Immunological, Genetic, and Clinical Challenges for Precision Medicine. [PDF]

J Clin Med
Dudek M, Górniak N, Ostrowski M, Złotowska A, Gajewski P.   +4 more
europepmc   +1 more source

Effects of anti-inflammatory agents on cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials. [PDF]

Am J Prev Cardiol
Perkovic A, Webster ER, Ridker PM, Tuttle KR, Perkovic V, Neuen BL.   +5 more
europepmc   +1 more source

A case of cryopyrin-associated periodic syndrome presenting with abdominal symptoms due to a novel mutation NLRP3 p.Ile257Met. [PDF]

Clin J Gastroenterol
Komatsu Y, Oizumi T, Yanai SI, Kobayashi Y, Nishio SY, Usami SI, Matsumoto T.   +6 more
europepmc   +1 more source

Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy. [PDF]

JACC Asia
Zeng RX, Li S, Li JJ.
europepmc   +1 more source

Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS). [PDF]

Pharmaceuticals (Basel)
Lei J, Lou Z, Jiang Y, Cui Y, Li S, Hu J, Jing Y, Yang J.   +7 more
europepmc   +1 more source

Case Report: Safety and efficacy of combination therapy with adalimumab and anakinra in two patients with severe inflammatory diseases. [PDF]

Front Pediatr
Coslovich S, Bramuzzo M, Pastore S, Chicco D, Lega S, Gortani G, Caiffa T, Tommasini A, Taddio A.   +8 more
europepmc   +1 more source

Pregnancy outcomes after maternal and paternal anti-IL-1 treatment exposure in cryopyrin-associated periodic syndromes (CAPS). [PDF]

Rheumatology (Oxford)
Satirer Ö, Henes J, Henes M, Benseler SM, Kuemmerle-Deschner JB.   +4 more
europepmc   +1 more source

Biological Therapies for Urate Lowering and Inflammation Control in Gout Management. [PDF]

J Inflamm Res
Zhou Y, Zhang H, Liu N, Yan H, Meng F, Peng J.   +5 more
europepmc   +1 more source